1. Home
  2. APLT vs QRHC Comparison

APLT vs QRHC Comparison

Compare APLT & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • QRHC
  • Stock Information
  • Founded
  • APLT 2016
  • QRHC N/A
  • Country
  • APLT United States
  • QRHC United States
  • Employees
  • APLT N/A
  • QRHC N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • QRHC Environmental Services
  • Sector
  • APLT Health Care
  • QRHC Utilities
  • Exchange
  • APLT Nasdaq
  • QRHC Nasdaq
  • Market Cap
  • APLT 44.0M
  • QRHC 41.8M
  • IPO Year
  • APLT 2019
  • QRHC N/A
  • Fundamental
  • Price
  • APLT $0.39
  • QRHC $2.10
  • Analyst Decision
  • APLT Buy
  • QRHC Strong Buy
  • Analyst Count
  • APLT 7
  • QRHC 2
  • Target Price
  • APLT $6.10
  • QRHC $12.75
  • AVG Volume (30 Days)
  • APLT 2.4M
  • QRHC 200.0K
  • Earning Date
  • APLT 08-06-2025
  • QRHC 08-07-2025
  • Dividend Yield
  • APLT N/A
  • QRHC N/A
  • EPS Growth
  • APLT N/A
  • QRHC N/A
  • EPS
  • APLT N/A
  • QRHC N/A
  • Revenue
  • APLT $265,000.00
  • QRHC $284,311,000.00
  • Revenue This Year
  • APLT $1,768.13
  • QRHC $4.34
  • Revenue Next Year
  • APLT $292.85
  • QRHC $6.28
  • P/E Ratio
  • APLT N/A
  • QRHC N/A
  • Revenue Growth
  • APLT N/A
  • QRHC N/A
  • 52 Week Low
  • APLT $0.30
  • QRHC $1.91
  • 52 Week High
  • APLT $10.62
  • QRHC $9.25
  • Technical
  • Relative Strength Index (RSI)
  • APLT 51.68
  • QRHC 47.06
  • Support Level
  • APLT $0.32
  • QRHC $1.97
  • Resistance Level
  • APLT $0.36
  • QRHC $2.24
  • Average True Range (ATR)
  • APLT 0.03
  • QRHC 0.15
  • MACD
  • APLT 0.00
  • QRHC -0.00
  • Stochastic Oscillator
  • APLT 73.78
  • QRHC 35.00

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

Share on Social Networks: